MaxCyte: Liontrust reports 4.92% ownership stake
The reported position carries sole voting and dispositive power, and the transaction table lists purchases as well as sales.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
For MaxCyte, Inc. (MXCT), Liontrust Investment Partners LLP reported beneficial ownership of 5,081,403 equity shares, or 4.9235% of the class, with sole voting and dispositive power over that amount. Its transaction table lists sales from August 6 through October 30, 2026, and purchases on October 14, including an October 30 sale of 112,919 shares and three October 14 purchases of 138,139, 175,694 and 43,113 shares. Jasmine Purohit signed as Compliance Executive.
Filing Explained
The filing’s heading calls this a major-shareholder acquisition above
Key Figures
Key Terms
beneficially owned regulatory
Sole Voting Power regulatory
Sole Dispositive Power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What purchases and sales did Liontrust report for MXCT?
AI-generated analysis. How Rhea-AI works. Not financial advice.